Octave Raises $52M in Series C 

Octave, a provider of outcomes-focused behavioral health care, secured $52 million in Series C funding to drive national expansion of evidence-based, in-network therapy services. The round was led by Cigna Ventures, Novo Holdings, and Avidity Partners, and joined by all existing institutional investors, Health Velocity Capital, Greycroft Partners, Felicis Ventures, Company Ventures, and Obvious Ventures.

Since launching in 2018, Octave now serves 18 million individuals across seven states: California, Connecticut, Florida, New Jersey, New York, Texas, and Washington, D.C. The company’s value-based care model has led to first-of-its-kind partnerships with major national payers.

The new funding will accelerate Octave’s expansion to more regions later this year and all 50 states in 2024, as well as the release of new technology products to serve payer and provider partners. This latest round of investment brings the company’s total funding to $86 million. Read more.

Total
0
Shares
Related Posts
Read More

Bridge to Life Raises $56M

The company is developing both warm and cold perfusion technologies for the enhanced preservation and transportation of livers, kidneys, lungs and hearts.